DGX vs. JNJ
Compare and contrast key facts about Quest Diagnostics Incorporated (DGX) and Johnson & Johnson (JNJ).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: DGX or JNJ.
Correlation
The correlation between DGX and JNJ is 0.30, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
DGX vs. JNJ - Performance Comparison
Key characteristics
DGX:
1.24
JNJ:
0.13
DGX:
2.00
JNJ:
0.31
DGX:
1.24
JNJ:
1.04
DGX:
1.15
JNJ:
0.14
DGX:
7.70
JNJ:
0.43
DGX:
3.46%
JNJ:
5.94%
DGX:
21.55%
JNJ:
18.88%
DGX:
-49.46%
JNJ:
-52.60%
DGX:
-7.22%
JNJ:
-9.99%
Fundamentals
DGX:
$18.22B
JNJ:
$369.29B
DGX:
$7.70
JNJ:
$5.79
DGX:
21.32
JNJ:
26.47
DGX:
1.54
JNJ:
1.09
DGX:
$7.51B
JNJ:
$67.44B
DGX:
$2.45B
JNJ:
$46.48B
DGX:
$1.46B
JNJ:
$19.10B
Returns By Period
In the year-to-date period, DGX achieves a 9.36% return, which is significantly higher than JNJ's 6.81% return. Over the past 10 years, DGX has outperformed JNJ with an annualized return of 10.33%, while JNJ has yielded a comparatively lower 7.30% annualized return.
DGX
9.36%
-4.55%
9.41%
27.49%
20.07%
10.33%
JNJ
6.81%
-7.19%
-2.86%
3.71%
5.63%
7.30%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
DGX vs. JNJ — Risk-Adjusted Performance Rank
DGX
JNJ
DGX vs. JNJ - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Quest Diagnostics Incorporated (DGX) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
DGX vs. JNJ - Dividend Comparison
DGX's dividend yield for the trailing twelve months is around 1.83%, less than JNJ's 3.24% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
DGX Quest Diagnostics Incorporated | 1.37% | 1.96% | 2.02% | 2.08% | 1.40% | 1.85% | 1.99% | 2.34% | 1.83% | 1.72% | 2.07% | 1.92% |
JNJ Johnson & Johnson | 3.24% | 3.40% | 3.00% | 2.52% | 2.45% | 2.53% | 2.57% | 2.74% | 2.38% | 2.73% | 2.87% | 2.64% |
Drawdowns
DGX vs. JNJ - Drawdown Comparison
The maximum DGX drawdown since its inception was -49.46%, smaller than the maximum JNJ drawdown of -52.60%. Use the drawdown chart below to compare losses from any high point for DGX and JNJ. For additional features, visit the drawdowns tool.
Volatility
DGX vs. JNJ - Volatility Comparison
The current volatility for Quest Diagnostics Incorporated (DGX) is 7.35%, while Johnson & Johnson (JNJ) has a volatility of 10.16%. This indicates that DGX experiences smaller price fluctuations and is considered to be less risky than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
DGX vs. JNJ - Financials Comparison
This section allows you to compare key financial metrics between Quest Diagnostics Incorporated and Johnson & Johnson. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities